LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Low-Cost, Easy to Use COVID-19 Saliva Test Provides Accurate Results within 30 Minutes

By LabMedica International staff writers
Posted on 08 Dec 2020
Image: Manu Prakash, PhD, associate professor of bioengineering and the inventor of the test (Photo courtesy of Stanford Medicine)
Image: Manu Prakash, PhD, associate professor of bioengineering and the inventor of the test (Photo courtesy of Stanford Medicine)
An at-home, COVID-19 saliva test that is designed to cost USD 5 or less uses no electricity and provides accurate results within 30 minutes.

The low-cost, fast saliva test for COVID-19 that will be the focus of a study at Stanford University School of Medicine (Stanford, CA, USA) involves little more than boiling some water, reading some instructions and spitting into a funnel. The test takes no more than 10 minutes to self-administer and is designed to detect the presence or absence of SARS-CoV-2 in saliva within 30 minutes, with an accuracy rate similar to that of the clinical tests performed in hospitals. A color display will appear yellow if there is a coronavirus infection or pink if there is no infection. The researchers estimate the kit’s retail cost, if the test is approved, to be as low as USD 5 and perhaps closer to USD 1. The test is also designed for easy, large-scale manufacture, which is crucial in the current pandemic.

“The world needs rapid-screening kits now, and at a very large scale,” said Manu Prakash, PhD, associate professor of bioengineering and the inventor of the test. “If the study is successful, our goal will be to manufacture tens of millions of them per day. We’re already building industrial partnerships to generate that capacity.”

“Our hope is to prove this works in the real world and then scale to hundreds of millions of tests to help open schools, universities and businesses as we wait for the vaccines now in development to come online,” said Euan Ashley, MB ChB, DPhil, associate dean in the School of Medicine and professor of cardiovascular medicine, of genetics and of biomedical data science.

Related Links:
Stanford Medicine

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gold Member
Hybrid Pipette
SWITCH

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more